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We examined factors associated with expanded crite-
ria donor (ECD) kidney discard. Scientific Registry of
Transplant Recipients (SRTR)/Organ Procurement and
Transplantation Network (OPTN) data were examined
for donor factors using logistic regression to determine
the adjusted odds ratio (AOR) of discard of kidneys
recovered between October 1999 and June 2005. Lo-
gistic and Cox regression models were used to deter-
mine associations with delayed graft function (DGF)
and graft failure. Of the 12536 recovered ECD kidneys,
5139 (41%) were discarded. Both the performance of
a biopsy (AOR = 1.21, p = 0.02) and the degree of
glomerulosclerosis (GS) on biopsy were significantly
associated with increased odds of discard. GS was not
consistently associated with DGF or graft failure. The
discard rate of pumped ECD kidneys was 29.7% versus
43.6% for unpumped (AOR = 0.52, p < 0.0001). Among
pumped kidneys, those with resistances of 0.26–0.38
and >0.38 mmHg/mL/min were discarded more than
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those with resistances of 0.18–0.25 mmHg/mL/min
(AOR = 2.5 and 7.9, respectively). Among ECD kid-
neys, pumped kidneys were less likely to have DGF
(AOR = 0.59, p < 0.0001) but not graft failure (RR =
0.9, p = 0.27). Biopsy findings and machine perfusion
are important correlates of ECD kidney discard; corre-
sponding associations with graft failure require further
study.
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Introduction
The use of organs from expanded criteria donors (ECDs)
has increased significantly over the past several years, and
recipients of ECD kidneys have a survival benefit when
compared with candidates who remain on the waiting list
(1,2). Based on data from the Scientific Registry of Trans-
plant Recipients (SRTR), ECD kidneys have been defined
as kidneys from donors aged 60 years or above, or from
donors aged 50–59 years with at least two of the following:
cerebrovascular accident (CVA) as cause of death, terminal
serum creatinine >1.5 mg/dL or a history of hypertension
(3). When compared with kidneys from a reference group
of normotensive donors aged 10–39 years with a termi-
nal creatinine <1.5 mg/dL and death from other causes,
kidneys from donors meeting the ECD definition have a
relative risk (RR) of graft loss greater than 1.70. The ECD al-
location system was designed to facilitate the allocation of
kidneys from these donors (4). Despite the increase in ECD
transplants and concerted efforts by the Organ Procure-
ment and Transplantation Network (OPTN) and the organ
procurement organization (OPO) community to increase
ECD use, discard rates for procured ECD kidneys remain
high (5).
ECD kidneys, by definition, have a high rate of graft fail-
ure, which contributes significantly to high discard rates.
While preimplantation biopsy and machine perfusion are
employed in the evaluation and management of kidneys
from ECD donors (5), the impact of these practices on uti-
lization and outcomes is uncertain. Therefore, we report on
the relationship of biopsy and pumping characteristics to
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The study used the SRTR/OPTN database, which includes data on all organ
donors and transplant recipients in the United States, supplemented by
the SRTR with mortality information from the Social Security Death Master
File. Analyses of kidney discard examined all kidneys procured for trans-
plantation in the United States between October 25, 1999, and June 30,
2005. Analyses of DGF and graft failure examined all kidneys transplanted
in the United States between October 25, 1999, and June 30, 2004. The
database includes information about pumping of kidneys by the OPO. In-
formation about pumping by the transplant center was not available for this
analysis. The predicted RR of graft failure was determined according to the
RRs given for combinations of the four donor characteristics used to define
ECD kidneys in the study by Port et al. (3). DGF was defined as the need
for dialysis within 1 week of transplantation. The rate of ECD kidney recov-
ery by donation service area (DSA) was determined as the percentage of
kidneys recovered for transplantation out of the number of ECD kidneys
available from deceased donors of at least one organ in the United States
between October 25, 1999 and June 30, 2005.
Analytical methods
All statistical analyses were performed using SAS software, version 9.1
(SAS Institute, Cary, NC). Unadjusted rates of discard were calculated as
the percentage of kidneys procured for transplantation but not transplanted
out of all kidneys procured for transplantation. The Pearson correlation co-
efficient r was used to determine the correlation between discard and re-
covery rates of ECD kidneys and between discard rates of ECD kidneys and
percentage of ECD transplantations out of total kidney transplantations for
each DSA. Logistic regression was used to determine the adjusted odds
ratio (AOR) of discard for various donor factors among all kidneys, ECD
kidneys and standard criteria donor (SCD) kidneys. Except in analyses test-
ing the effect of adjusting for each individual DSA (i.e. area of each OPO)
as a covariate, generalized estimating equations were used to account for
clustering at the OPO level, assuming a compound symmetry covariance
structure. This method accounts for the fact that kidneys recovered within
an OPO may be more similar to each other than to kidneys recovered in
Table 1: Adjusted odds of discard for all deceased donor kidneys (n = 63 983)
Donor characteristic % Discarded % of all organs Adjusted odds ratio p-Value
DCD (ref = non-DCD) 20.8 (8.0) 4.1 3.05 <0.0001
ECD (ref = non-ECD) 41.0 (8.0) 19.6 4.35 <0.0001
Pumped (ref = not pumped) 15.2 (14.8) 13.9 0.57 0.0006
Biopsy1 (ref = no biopsy) 7.9 68.9
0–5% glomerulosclerosis 18.6 18.4 1.50 <0.0001
6–10% glomerulosclerosis 30.7 4.3 2.40 <0.0001
11–15% glomerulosclerosis 41.0 2.0 3.49 <0.0001
16–20% glomerulosclerosis 57.2 1.4 6.81 <0.0001
20%+ glomerulosclerosis 75.5 3.7 16.92 <0.0001
Diabetes (ref = no diabetes) 39.5 (13.5) 5.6 1.89 <0.0001
Male (ref = female) 13.4 (17.2) 58.7 0.96 0.16
African American (ref = non-AA) 17.8 (14.6) 12.2 1.27 <0.0001
Adjusted for listed factors as well as diabetes status missing, biopsy information missing, percentage glomerulosclerosis missing and
pumping information missing.
1For biopsy versus no biopsy: OR = 2.08; p < 0.0001.
other OPOs due to OPO-specific practices. In analyses testing the effects
of adjusting for each DSA as a covariate, the contribution of the adjustments
for DSA/OPO was tested using the likelihood ratio test.
Additional logistic regression models were used to determine whether fac-
tors predictive of discard were predictive of DGF. Generalized estimating
equations were used to account for clustering at the OPO level, as de-
scribed above. Cox regression models were used to determine whether
factors predictive of discard were predictive of graft failure. Standard errors
were adjusted for OPO clustering. Graft failure was defined by a record
of graft failure, retransplantation or return to maintenance dialysis and was
censored at the earliest of death, last follow-up or last expected follow-
up. Creatinine clearance at 1-year posttransplant was calculated using the
Cockroft Gault formula. For those with graft failure before 1 year, a value of
10 mL/min was assumed. The relationship between biopsy results and cre-
atinine clearance at 1 year was analyzed with ordinary least squares linear
regression. The adjusted mean creatinine clearance is the mean creatinine
clearance for those in each group who also have zero (reference) for all
the other parameters in the model, and is therefore different (in this case,
greater) than the unadjusted creatinine clearance for each group.
Because the determinants of discard for kidneys from donors after cardiac
death (DCD donors) were assumed to be different from those of kidneys
from donors after brain death, they were excluded from all analyses except
as described in Table 1. Some risk factors for ECD kidney discard were
compared with those for SCD kidneys, which are defined as kidneys from
donors after brain death who do not meet the ECD definition.
Results
Of the 48796 SCD kidneys procured during the study pe-
riod, 8% (3887) were discarded. In contrast, 41% (5139)
of 12536 ECD kidneys were discarded. In a logistic model
including all recovered kidneys, ECD kidneys were more
than four times (AOR = 4.35, p < 0.0001) and DCD kidneys
were more than three times (AOR = 3.05, p < 0.0001) as
likely to be discarded as non-ECD kidneys (Table 1). When
compared with the odds of ECD kidney discard, the AOR
for DCD kidney discard was 0.70 (p = 0.0004).
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Table 2: Adjusted odds of discard by ECD RR group and biopsy results (n = 12 536)
Donor characteristic % Discarded % of ECD organs Adjusted odds ratio p-Value
Diabetes (ref = no diabetes) 57.3 (38.4) 13.8 1.96 <0.0001
Biopsy1 (ref = no biopsy) 38.5 24.8
0–5% glomerulosclerosis 26.5 35.9 0.57 <0.0001
6–10% glomerulosclerosis 38.7 12.0 0.98 0.84
11–15% glomerulosclerosis 47.2 6.2 1.39 0.0006
16–20% glomerulosclerosis 65.4 4.5 3.04 <0.0001
20%+ glomerulosclerosis 83.1 12.3 7.22 <0.0001
Male (ref = female) 42.4 (39.7) 47.8 1.24 <0.0001
African American (ref = non-AA) 47.0 (40.2) 11.6 1.43 <0.0001
Pumped (ref = not pumped) 29.7 (43.3) 18.8 0.52 <0.0001
ECD RR Group
1.70–1.99 31.4 44.0 1.00 ref
2.00–2.39 40.8 27.2 1.70 <0.0001
2.40+ 55.9 28.8 2.90 <0.0001
Adjusted for listed factors as well as biopsy information missing, percentage glomerulosclerosis missing and pumping information
missing.
1For biopsy versus no biopsy: OR = 1.21; p = 0.02.
Impact of biopsy on kidney discard
Among all kidneys, those that were biopsied were more
likely to be discarded (AOR = 2.08, p < 0.0001), as were
those from diabetics (AOR = 1.89, p < 0.0001) and African
American donors (AOR = 1.27, p < 0.0001) (Table 1). The
odds of discard increased progressively with increasing de-
grees of glomerulosclerosis (GS), ranging from an AOR of
1.50 for kidneys with 0–5% GS (compared with those not
biopsied) to 16.92 for those with greater than 20% GS
(Table 1).
ECD kidneys were biopsied in 74.8% of cases, compared
with 18.7% of cases for SCD kidneys. Overall, biopsied
ECD kidneys had a higher rate of discard than ECD kidneys
that were not biopsied (AOR = 1.21, p = 0.02); kidneys
from male (AOR = 1.24, p < 0.0001 compared with fe-
male) and African American (AOR = 1.43, p < 0.0001, com-
pared with non-African American) ECD kidney donors also
had a higher rate of discard. With increasing GS on biopsy,
the odds of ECD kidney discard compared with those not
biopsied increased from an AOR of 0.57 (p < 0.0001)
for ECD kidneys with GS of 0–5% to 7.22 (p < 0.0001)
Table 3: Adjusted odds of discard for SCD (n = 48 796)
Donor characteristic % Discarded % of SCD organs Adjusted odds ratio p-Value
Diabetes (ref = no diabetes) 21.2 3.5 1.46 0.0017
Biopsy1 (ref = no biopsy)
0–5% glomerulosclerosis 12.6 13.1 2.68 <0.0001
6–10% glomerulosclerosis 19.7 2.3 4.45 <0.0001
11–15% glomerulosclerosis 28.9 0.9 7.23 <0.0001
16–20% glomerulosclerosis 42.0 0.6 12.39 <0.0001
20%+ glomerulosclerosis 59.6 1.5 25.12 <0.0001
Male (ref = female) 7.2 61.1 0.87 0.0009
African American (ref = non-AA) 10.6 12.5 1.27 0.0002
Pumped (ref = not pumped) 7.8 10.5 0.64 0.102
Adjusted for listed factors as well as biopsy information missing, percentage glomerulosclerosis missing and pumping information missing.
1For biopsy versus no biopsy: OR = 4.21; p < 0.0001.
for ECD kidneys with GS in excess of 20% (Table 2).
In contrast to that of ECD kidneys, the AOR of discard for
biopsied SCD kidneys was 4.21 (p < 0.0001, Table 3) com-
pared with those not biopsied. Similar to the overall model
in Table 1, all levels of GS were associated with higher odds
of discard than SCD kidneys that were not biopsied.
Discard rates also increased in the presence of each of the
individual components of the ECD definition. Each year of
donor age above age 50 was associated with a 12% in-
crease (p < 0.0001), death from CVA with an 18% increase
(p = 0.053) and a history of hypertension with a 69% in-
crease (p < 0.0001) in the AOR of discard. A serum creati-
nine at allocation of >1.5 mg/dL was particularly predictive
of discard, with an AOR of 3.45 (p > 0.0001) (Table 4).
These characteristics predictive of allograft failure were
combined to generate risk categories for transplant failure.
The odds of ECD discard increased with increasing allograft
failure category, from an AOR of 1.00 for ECD kidneys with
an RR between 1.70 and 1.99 to an AOR of 2.90 for ECD
kidneys with an RR of allograft failure of 2.40 or greater
(Table 2). Unadjusted discard rates ranged from 19% for
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Table 4: Adjusted odds of discard by ECD components (n =
12 536)
Donor characteristic Adjusted odds ratio p-Value
Serum creatinine >1.5 mg/dL 3.45 <0.0001
CVA as cause of death 1.18 0.053
Hypertension 1.69 <0.0001
Donor age (per year above 50) 1.12 <0.0001
Adjusted for listed factors and those in Table 2 (except ECD
RR group) as well as biopsy information missing, percentage
glomerulosclerosis missing and pumping information missing.
ECD kidneys with the least GS and the lowest projected
RR of graft failure to 90% for ECD kidneys with greater
than 20% GS and high RR (Figure 1). In adjusted models,
the AOR of ECD kidney discard within each RR category
increased with increasing degrees of GS on biopsy (not
shown).
Method of kidney preservation and discard
Machine perfusion by the OPO was used in 18.8% of
ECD kidneys. Pumped ECD kidneys were discarded in
29.7% of cases, compared with 43.6% for ECD kid-
neys that were not pumped. In the logistic model of
ECD discard, pumped ECD kidneys were 48% less likely
to be discarded than those not pumped (p < 0.0001)
(Table 2). This contrasts with the 36% reduction in the
odds of discard for pumped SCD kidneys (AOR = 0.64,
p = 0.102). Pumped ECD kidneys with high resistance
values were associated with higher odds of discard (Fig-
ure 2). ECD kidneys with terminal resistances <0.18 and
between 0.18–0.25 mmHg/mL/min were discarded only
12.6% and 14.0% of the time, respectively (Figure 2).
When compared to ECD kidneys with terminal resistances
of 0.18–0.25 mmHg/mL/min, those with resistances of
0.26–0.38 mmHg/mL/min had a 25.7% discard rate
(AOR = 2.50, p < 0.0001) and those with resistances >0.38
mmHg/mL/min had a 53.1% discard rate (AOR = 7.88,
p < 0.0001).
Figure 1: Unadjusted discard rates
for ECD kidneys (n = 12 536).
Local variation in kidney discard rates
There was substantial variation in unadjusted discard rates
for both ECD and non-ECD kidneys among DSAs; the
discard rate for ECD kidneys ranged from 14% to 60%
(Figure 3). In a logistic model adjusting for various donor
factors, there was a nearly 10-fold difference in the AOR
of discard between the DSAs with the highest and low-
est adjusted discard rates (0.44–3.86). For all classes of
kidneys, including pumped ECD kidneys, and in all RR cat-
egories, the inclusion of DSA effects significantly improved
the fit of the discard model, indicating that DSA practices
were significant determinants of discard (Table 5). How-
ever, inclusion of DSA effects did not diminish the signifi-
cance of the other factors in the discard model outlined in
Table 2 (not shown), suggesting that they are independent
factors.
To determine whether DSAs that are more likely to dis-
card ECD kidneys are also more likely to discard SCD
kidneys, DSAs were divided into tertiles based on ECD
discard rates. A logistic model of discard indicated that
DSAs with high ECD discard rates were also more likely
to discard SCD kidneys (Figure 4). It is notable, how-
ever, that the differences between the high- and the low-
discard tertile DSAs were smaller for SCD (AOR = 1.86
for the high-discard tertile compared with the low-discard
tertile, p < 0.0001) than for ECD kidneys (AOR = 2.69,
p < 0.0001). There were no significant interactions be-
tween the other discard predictors and tertiles of ECD dis-
card (not shown), further demonstrating that the effects
of DSA on discard are not based on these specific donor
characteristics.
There was a negative correlation between discard rates
and recovery rates among DSAs that approached statistical
significance (r = –0.235, p = 0.0729); i.e. those DSAs with
higher recovery rates tended to have lower discard rates.
Furthermore, in those DSAs with a high percentage of ECD
transplants, ECD discard rates were lower than in those
DSAs with relatively few ECD transplants (r = –0.331, p =
0.01).
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Figure 2: Adjusted odds of ECD dis-
card by resistance level for pumped
kidneys (n = 2351).
Kidney biopsy, preservation method
and transplant outcome
The AOR of DGF was significantly lower in those ECD kid-
neys that were pumped (AOR = 0.59, p < 0.0001) (Table 6).
Compared with a reference group of nonbiopsied ECD kid-
neys, the AOR of DGF was greater for biopsied ECD kid-
neys (AOR = 1.16, p = 0.03); however, in contrast to the
effects on discard, no relationship could be demonstrated
between the degree of GS and the odds of DGF. Further-
Figure 3: Unadjusted discard
rates by DSA for ECD.
more, the ECD RR category did not significantly correlate
with the odds of DGF.
In a Cox model of ECD graft failure, the RR of graft fail-
ure was not significantly different in pumped ECD kidneys
(RR = 0.91, p = 0.27) (Table 7) compared with those not
pumped. The risk of graft failure for biopsied ECD kidneys
was also not different from those not biopsied (RR = 0.97,
p = 0.62). Interestingly, there was no clear relationship
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Table 5: Effect of DSA on probability of discard
Study group Total n % Discarded 10th percentile DSA 90th percentile DSA
All kidneys 63978 15.0 10.0 21.6
Pumped kidneys 8886 15.2 0 66.7
Non-ECD kidneys 51442 8.6 5.3 12.4
ECD kidneys 12,536 41.0 26.0 52.5
Pumped ECD kidneys 2351 29.7 13.9 72.5
ECD RR 1.70–1.99 5520 31.4 16.7 45.3
ECD RR 2.0–2.4 3411 40.8 18.0 58.3
ECD RR 2.4+ 3605 55.9 39.4 73.6
Pumped kidneys (excluding DCD) 7456 14.7 3.1 66.7
SCD 48796 8.0 4.5 11.9
SCD and ECD 61327 14.7 9.9 20.6
p < 0.0001 for test of DSA effect in each of the 11 analyses.
between degree of GS on biopsy and the RR of graft failure
(p = ns for all categories compared with no biopsy). In addi-
tion, among biopsied kidneys, those transplanted kidneys
with GS of 6% or greater did not have higher graft failure
rates than those with little or no (0–5%) GS. In a linear
regression model for creatinine clearance at 1 year after
transplant, most categories of ECD kidneys with GS of 6%
or greater had significantly lower adjusted creatinine clear-
ance than those with 0–5% GS or that were not biopsied
(Table 8). However, among kidneys with greater than 6%
GS, a relationship between categories of GS and graft func-
tion was not identified. Failure rates were higher for ECD
kidneys from African American (AOR = 1.22, p = 0.16) and
diabetic (AOR = 1.23, p = 0.013) donors and for those in
the higher risk of graft failure ECD cohorts.
Discussion
One of the difficulties encountered in attempting to in-
crease the number of kidney transplants has been the iden-
tification of marginal kidneys with an acceptable likelihood
Figure 4: ECD versus SCD discard
by DSA tertiles of ECD discard.
of graft survival. While the ECD definition has established
some uniform criteria for higher-risk kidneys, a great deal
of uncertainty and disagreement remains over what con-
stitutes a suitable kidney (6,7).
Efforts to increase the use of ECD kidneys led to the es-
tablishment of the ECD allocation system, implemented by
the OPTN on October 31, 2002 (4). ECD kidney utilization
has increased significantly under the ECD system, from
1230 transplants performed in 2002 to 1609 in 2005 (1).
However, despite elements of the system specifically de-
signed to minimize the time to placement and reduce the
likelihood of discard due to prolonged cold ischemia, ECD
discard rates have not changed under the ECD system,
nor have they changed appreciably over the last 5 years
(5). Although discard rates for the highest risk (RR > 2.4)
ECD kidneys decreased from 68% to 51% under the ECD
system between November 2002 and April 2004, this re-
duction was offset by an increase in the discard rates of
the lowest risk (RR 1.7–1.99) ECD kidneys from 24% to
28%. This raises the possibility that, with the institution of
a formal ECD definition, kidneys not previously regarded
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Table 6: Adjusted odds of DGF for transplanted ECD kidneys (n = 5899)
Among all ECD n = 5899 Among biopsied n = 4308
Donor characteristic Adjusted odds ratio p-Value Adjusted odds ratio p-Value
Pumped (ref = not pumped) 0.59 <0.0001
Biopsy–% glomerulosclerosis (ref = no biopsy1)
0–5% 1.13 0.07 1.00 ref
6–10% 1.29 0.009 1.14 0.13
11–15% 1.10 0.47 0.96 0.74
16–20% 1.50 0.004 1.30 0.04
20%+ 1.38 0.07 1.21 0.25
Male (ref = female) 1.20 0.002
African American (ref = non-AA) 0.98 0.82





1For biopsy versus no biopsy: OR = 1.16; p = 0.03.
Adjusted for factors in table as well as recipient age, sex, race, cause of end-stage renal disease, panel reactive antibody, cold ischemia
time and HLA mismatch.
as marginal are now identified as such and that there may
be currently unrecognized determinants of discard beyond
those covered by the ECD definition, pump characteristics
and percentage of GS on biopsy.
The current analyses update those originally developed by
the OPTN Organ Availability and Kidney-Pancreas Commit-
tees and the SRTR. They demonstrate that, as expected,
ECD kidneys are more than four times as likely to be dis-
carded than non-ECD kidneys. The additional finding that
DCD kidneys are more than three times as likely to be dis-
carded than non-DCD kidneys is pertinent in light of reports
demonstrating comparable graft survival (8). Factors tradi-
Table 7: Adjusted RR of graft failure for transplanted ECD kidneys
Among all ECD n = 5899 Among biopsied n = 4308
Donor characteristic RR p-Value RR p-Value
Pumped (ref = not pumped) 0.91 0.27
Biopsy–% glomerulosclerosis (ref = no biopsy1)
0–5% 0.93 0.22 1.00 ref
6–10% 1.05 0.63 1.12 0.26
11–15% 1.16 0.26 1.23 0.13
16–20% 0.99 0.97 1.05 0.76
20%+ 1.15 0.35 1.24 0.15
Male (ref = female) 0.96 0.36
African American (ref = non-AA) 1.22 0.016





1For biopsy versus no biopsy: OR = 0.97; p = 0.62.
Adjusted for factors in table as well as recipient age, sex, race, cause of end-stage renal disease, panel reactive antibody, cold ischemia
time and HLA mismatch.
Analysis censored for death with graft function.
tionally thought to contribute to graft failure, such as dia-
betes, are indeed associated with discard of ECD kidneys.
In addition, each of the components of the ECD definition is
significantly associated with the odds of discard. For these
risk factors, there is concordance between acceptance
behavior and outcomes.
The use of biopsy is an important practice in the evaluation
of ECD kidneys, in contrast to the evaluation of non-ECD
kidneys. Three-fourths (74.8%) of ECD kidneys were biop-
sied in this analysis (compared with 18.7% of non-ECD
kidneys), and biopsy findings are the most frequently cited
reason for the discard of recovered ECD kidneys (51% in
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Table 8: Mean creatinine clearance1 at 1 year after ECD kidney transplant by biopsy characteristics
p-Value (adjusted)
Mean CrCl Mean CrCl Among Among
Biopsy–% GS (unadjusted) SD (unadjusted) (adjusted) all ECD biopsied
No biopsy 44.60 23.18 52.61 Reference
0–5% 45.00 23.54 53.66 0.21 Reference
6–10% 41.52 22.09 50.64 0.09 0.005
11–15% 40.16 23.70 49.03 0.03 0.003
16–20% 42.37 20.03 51.08 0.48 0.230
20%+ 38.84 27.15 48.26 0.03 0.005
1Creatinine clearance of failed transplants was set at 10 cc/min.
Adjusted for donor age, race, diabetes and pumping status as well as recipient age, sex, race, cause of end-stage renal disease, panel
reactive antibody, cold ischemia time and HLA mismatch.
the 18 months following ECD policy implementation) (5).
While all biopsied kidneys were more likely to be discarded,
this was more striking for SCD than for ECD kidneys. This
may reflect the common OPO practice of routinely per-
forming a biopsy on all ECD kidneys, whereas most SCD
kidneys are biopsied selectively based on the presence of
other donor risk factors. There was a direct relationship be-
tween the percentage of GS identified on biopsy and the
odds of discard for both ECD and non-ECD kidneys, with a
greater than 12-fold difference between ECD kidneys with
>20% GS compared with those with less than 5%. There-
fore, the perception of the degree of chronic disease as
reflected in the biopsy findings was a significant factor in
whether a kidney was discarded.
Although biopsy findings were an important determinant of
discard, we were unable to demonstrate associations with
DGF and graft failure in this registry-based analysis. While
we did observe an association between performance of a
biopsy and DGF, whether this reflects differences in those
kidneys that were selected for biopsy (for those OPOs that
do not routinely biopsy ECD kidneys) or a causal relation-
ship could not be established by this study. Among biop-
sied kidneys, no consistent patterns of DGF or graft failure
were identified with respect to GS. This was not likely to
be a consequence of unequal follow-up, since follow-up be-
tween kidneys with higher and lower degrees of GS were
similar (<20% GS –2.80 ± 1.38 years, >20% GS –2.84 ±
1.45, not biopsied/missing –2.98 ± 1.37). While the asso-
ciations between GS of 6% or greater and graft function,
as measured by creatinine clearance at 1 year, were not
reproduced in the graft survival analyses, a possible effect
over a longer timeframe cannot be excluded.
The importance of biopsy as a determinant of utilization and
graft outcomes has received increasing attention. While it
seems obvious that evidence of chronic injury, especially in
the setting of established risk factors such as age and hy-
pertension, should portend poor outcomes, no large stud-
ies exist to confirm this. Edwards et al. demonstrated an
effect of GS in kidneys with low creatinine clearance on
unadjusted, but not adjusted, graft survival (9). Cecka has
observed that while biopsy findings are the most frequently
cited reasons for discard in the US, performance of biopsy
is rarely noted in the Eurotransplant experience, where dis-
card of kidneys from elderly donors is much lower (10).
However, Remuzzi found biopsy to be an important instru-
ment in selecting kidneys to be used successfully for dual
transplant (11). Among other studies, the impact of biopsy
findings on early graft function and graft survival range from
no effect to significant effects that correlate with donor age
or creatinine clearance to effects that are independent of
other donor covariates (12,13).
There are several inherent limitations to the use of registry
data in the analyses of biopsy in kidney transplantation. Re-
liance on frozen section results that are often read in the
donor hospital implies variation in the interpretation of indi-
vidual biopsies. The technique of biopsy employed (wedge
vs. core) and the number of glomeruli identified, which are
not reported on the deceased donor registration form, may
influence biopsy results and interpretations. These limita-
tions are likely to lead to misclassifications that underesti-
mate the effects of different degrees of GS on DGF and
graft failure. The OPTN data are also limited to intervals of
glomerulosclerosis up to 20%; discrimination within these
intervals or among degrees of glomerulosclerosis greater
than 20% was not possible. Other relevant biopsy parame-
ters such as interstitial fibrosis and arteriosclerosis, which
are not collected and therefore could not be studied, have
been identified as potentially greater determinants of graft
outcome than GS (12,13).
An additional important limitation to registry analyses of
biopsy data is the inherent potential for selection bias.
By definition, the transplanted kidneys in this cohort with
greater degrees of glomerulosclerosis were more carefully
selected, since such kidneys were much less frequently
transplanted (only 17% of transplanted ECD kidneys with
biopsy showed greater than 10% GS). While the models of
DGF and graft failure adjust for a large number of donor, re-
cipient and transplant-related factors, kidneys with higher
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degrees of glomerulosclerosis are likely to be more care-
fully selected for unreported factors, including other biopsy
characteristics, which are more likely to be favorable than
for kidneys with lesser GS. Such biases would diminish the
potential adverse effects of glomerulosclerosis in the out-
come models. Clinical trials where biopsies are performed
in a standardized fashion and interpreted in a consistent
manner, such as the prospective, multi-OPO study cur-
rently being performed in New England and Michigan (14),
have advantages over registry data in this regard.
While only 19% of ECD kidneys in this study were pumped,
there was a significant association between pumping and
discard. Although it might seem that those DSAs that pump
kidneys may be less likely to discard ECD kidneys based on
overall DSA behavior, pumping was associated with lower
discard rates even when adjusting for DSA effects. It ap-
pears that the effect of pumping ECD kidneys is not merely
that kidneys with poor resistance profiles that might have
been used are discarded, because this would lead to an in-
crease in the discard rate. Rather, it appears probable that
centers are using kidneys that would have been discarded
if they were not pumped. While the association with de-
creased DGF rates is consistent with other single-center
and registry studies and at least one meta-analysis of ma-
chine perfusion on early graft outcomes (15–18), the liter-
ature regarding long-term graft survival is less conclusive.
The mechanisms by which machine perfusion might im-
prove early graft outcomes are controversial and remain to
be determined. On the one hand, the information gained
during perfusion regarding flow and resistance may permit
the selection of kidneys destined to have acceptable out-
comes, and the current study clearly demonstrates that ter-
minal resistance is an important consideration in this selec-
tion process. Alternatively, the observation that renal flow
may increase and resistance may decrease with increas-
ing perfusion time suggests that the hydrostatic effects
of machine perfusion may reduce intrarenal vasoconstric-
tion (17). In addition, evidence suggests that additives to
pumped preservation solutions may ameliorate ischemia-
reperfusion injury (17,19).
It is important to recognize that the association of pump-
ing and discard does not prove a cause-effect relationship.
Adjustments may be made to account for the possibility
that those DSAs where kidneys are more often pumped
may also have practices unrelated to pumping that lead to
lower discard rates. However, selection biases may exist
within DSAs that may result in the more frequent pump-
ing of kidneys that are less likely to be discarded based
on other donor characteristics. Therefore, while it may be
tempting to conclude that pumped kidneys are less likely to
be discarded, the opposite relationship, that kidneys with a
low likelihood of discard are more likely to be pumped, can-
not be ruled out. Similar caveats apply to the association
between pumping and DGF.
Other limitations to the use of OPTN/SRTR data in analyses
of machine perfusion include variability among and within
DSAs in perfusion techniques and duration of machine per-
fusion. In some DSAs, kidneys remain on the pump until
transplantation; in others, kidneys are pumped and then
placed into cold storage for local transportation. Until re-
cently, the OPTN captured pumping data on the deceased
donor registration form only if the kidney was pumped at
the recovering DSA. Therefore, data on kidneys that were
transported and then pumped at the transplant recipient’s
center were not captured. This leads to an underestima-
tion of the number of pumped kidneys. The effect of these
omissions is to underestimate the effect of pumping on dis-
card, DGF and graft survival, so the differences observed
in this study may be larger with more accurate data cap-
ture. The revised deceased donor recipient transplant form
includes fields for pumping at the transplant recipient cen-
ter (or DSA), so future analyses should benefit from this
modification.
There was significant DSA variation in discard rates that
was not attributable to differences in the prevalence of
donor risk factors that clearly indicates that different DSAs
have different thresholds of use of ECD kidneys. The ap-
proach to utilization of ECD kidneys appears to be simi-
lar to SCD kidneys, because those DSAs likely to discard
ECD kidneys were also more likely to discard SCD kid-
neys. These different behaviors were not limited to specific
donor characteristics but appeared to be broadly applied,
because their impact on the odds of discard was not no-
tably changed by consideration of DSA effects. Because
discard of ECD kidneys was less likely in DSAs that re-
covered and transplanted more ECD kidneys, differences
among DSAs may reflect different needs for and attitudes
toward ECD kidney transplantation. This DSA variation
is currently being addressed by several OPTN committees
and by the Organ Donation Breakthrough Collaborative,
with greater information being communicated to individ-
ual OPOs regarding their specific utilization data.
It should not be surprising that approaches to ECD kidneys
differ among DSAs, because the estimated benefit of an
ECD kidney depends in large part on the likelihood of re-
ceiving a non-ECD kidney, which is not equal among DSAs.
There are other differences among DSAs not considered
in these analyses that may contribute to ECD utilization,
including DSA waiting time, attitudes regarding appropri-
ate recipients for ECD kidneys and the composition of the
waiting list. However, it is important to recognize that kid-
neys that are discarded in some DSAs may be readily used
in others, and efficient mechanisms to shift ECD kidneys
from DSAs and centers with low utilization rates to those
with high rates must be developed to maximize overall
kidney utilization. To the extent that pumping and perhaps
biopsy may facilitate acceptance by centers with high uti-
lization rates under an expedited mechanism, the expan-
sion of these practices may be desirable.
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Conclusion
ECD kidneys are frequently discarded due to features that
have been previously associated with inferior graft out-
comes, such as those criteria that constitute the current
ECD definition. Biopsy findings and characteristics of ma-
chine perfusion are also important determinants of discard,
although their effects on graft outcomes are more difficult
to demonstrate. The finding of a lower risk for DGF in ECD
kidneys that were transplanted without a biopsy suggests
selection and indicates the need for a study with prospec-
tive biopsies of all ECD organs. The substantial variation in
DSA discard rates is not restricted to specific donor char-
acteristics but is likely to reflect a spectrum of approaches
toward ECD transplantation.
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